Scientists spent the next three decades teasing apart the underpinnings of viral biology to create a new generation of vectors. Among these, lentivirus-based vectors, derived from the HIV-1 ...

However, it is often difficult for scientists to ramp up the generation of these vectors to meet their needs at each stage of ... Download this application note from Thermo Fisher Scientific to learn ...

ESO-T01 is the first in vivo BCMA CAR-T candidate to reach the clinical stageEarly clinical data are expected in second half of ...